tradmap

USPH Earnings U S Physical Therapy Inc /Nv

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
$0 $1 $2 2013 2014 2015 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $390M $781M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
$0 $20M $41M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 $0 $1 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $107M $214M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
$0 $7M $13M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–60 of 60
Q2 20262026-06-300.252026-08-0710-Q
Q1 20262026-03-31-0.122026-05-0810-Q
Q4 2025 (derived)2025-12-31-0.442026-02-2710-K
FY 20252025-12-311.422026-02-2710-K
Q3 20252025-09-300.482025-11-0710-Q
Q2 20252025-06-300.582025-08-0810-Q
Q1 20252025-03-310.802025-05-0910-Q
Q4 2024 (derived)2024-12-310.522025-03-0310-K
FY 20242024-12-311.842025-03-0310-K
Q3 20242024-09-300.392024-11-0810-Q
Q2 20242024-06-300.472024-08-1410-Q
Q1 20242024-03-310.462024-05-0810-Q
Q4 2023 (derived)2023-12-31-0.452024-02-2910-K
FY 20232023-12-311.282024-02-2910-K
Q3 20232023-09-300.512023-11-0810-Q
Q2 20232023-06-300.642023-08-0910-Q
Q1 20232023-03-310.582023-05-0510-Q
Q4 2022 (derived)2022-12-31-0.012023-02-2810-K
FY 20222022-12-312.252023-02-2810-K
Q3 20222022-09-300.722022-11-0810-Q
Q2 20222022-06-300.872022-08-0810-Q
Q1 20222022-03-310.672022-05-0910-Q
Q4 2021 (derived)2021-12-310.722022-03-0110-K
FY 20212021-12-312.412022-03-0110-K
Q3 20212021-09-300.662021-11-0910-Q
Q2 20212021-06-300.822021-08-0910-Q
Q1 20212021-03-310.212021-05-1010-Q
Q4 2020 (derived)2020-12-310.68——
FY 20202020-12-312.48——
Q3 20202020-09-300.61——
Q2 20202020-06-300.99——
Q1 20202020-03-310.20——
FY 20192019-12-312.45——
Q3 20162016-09-300.462016-11-0410-Q
Q2 20162016-06-300.572016-08-0510-Q
Q1 20162016-03-310.432016-05-0610-Q
Q4 20152015-12-310.482016-03-0410-K
FY 20152015-12-311.772016-03-0410-K
Q3 20152015-09-300.472015-11-0510-Q
Q2 20152015-06-300.482015-08-0610-Q
Q1 20152015-03-310.342015-05-0710-Q
Q4 20142014-12-310.412015-03-1210-K
FY 20142014-12-311.622015-03-1210-K
Q3 20142014-09-300.432014-11-0710-Q
Q2 20142014-06-300.522014-08-0710-Q
Q1 20142014-03-310.272014-05-0910-Q
Q4 20132013-12-310.322014-03-1110-K
FY 20132013-12-311.052014-03-1110-K
Q3 20132013-09-300.022013-11-0710-Q
Q2 20132013-06-300.412013-08-0810-Q
Q1 20132013-03-310.312013-05-0910-Q
Q4 20122012-12-310.332013-03-1210-K
FY 20122012-12-311.512013-03-1210-K
Q3 20122012-09-300.382012-11-0910-Q
Q2 20122012-06-300.40——
Q1 20122012-03-310.372012-05-0410-Q
Q4 20112011-12-310.69——
FY 20112011-12-311.752012-03-0910-K
Q3 20112011-09-300.342011-11-0810-Q
Q2 20112011-06-300.412011-08-0410-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.